Sign in

CIK 0001640266 · Accelerated filer<br>Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-06 GERAGHTY JAMES A Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2023-06-06 SCANGOS GEORGE A Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2023-06-06 Hyman Steven Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2023-05-09 SCANGOS GEORGE A Director Grant or award · Stock Option (Right to Buy) +44,000 44,000
2023-04-03 Sandrock Alfred President and CEO Sale −7,437 $7.83 $58K 214,618
2023-04-03 Swartz Robin Chief Operating Officer Sale −1,259 $7.83 $10K 71,617
2023-02-23 NEUROCRINE BIOSCIENCES INC 10% owner Purchase +4,395,588 $8.88 $39.0M 8,575,316
2015-11-16 Sanofi Former 10% owner Purchase +125,000 $14.00 $1.8M 2,477,941
2015-11-10 Sanofi Former 10% owner Conversion +2,352,941 2,352,941
2015-11-10 Sanofi Former 10% owner Conversion · Shares of Series B convertible preferred stock −10,000,000 0

Page 7 of 7 · 130 trades